Natural Disease Course in Usher Syndrome Patients Harboring


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
05 03 2023
Historique:
received: 08 12 2022
revised: 08 02 2023
accepted: 13 02 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

The aim of the study was to determine the rate of retinal degeneration in patients with c.2610C>A (p.Cys870*) in

Identifiants

pubmed: 36980924
pii: genes14030652
doi: 10.3390/genes14030652
pmc: PMC10048357
pii:
doi:

Substances chimiques

USH2A protein, human 0
Extracellular Matrix Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Biochem Cell Biol. 2014 Jan;46:80-9
pubmed: 24239741
Mol Ther. 2021 Aug 4;29(8):2441-2455
pubmed: 33895329
Transl Vis Sci Technol. 2019 Jun 11;8(3):36
pubmed: 31211001
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5532-9
pubmed: 18641288
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4413-8
pubmed: 17360538
Genes (Basel). 2019 Nov 21;10(12):
pubmed: 31766479
Int J Audiol. 2007 Feb;46(2):82-93
pubmed: 17365059
Genes (Basel). 2017 Oct 05;8(10):
pubmed: 28981474
PLoS One. 2018 Jun 18;13(6):e0199048
pubmed: 29912909
Diagnostics (Basel). 2021 Feb 01;11(2):
pubmed: 33535592
Int J Mol Sci. 2021 Sep 26;22(19):
pubmed: 34638692
Doc Ophthalmol. 2016 Aug;133(1):1-9
pubmed: 27443562
Exp Eye Res. 2020 Dec;201:108330
pubmed: 33121974
Curr Opin Neurol. 2012 Feb;25(1):42-9
pubmed: 22185901
Doc Ophthalmol. 2022 Jun;144(3):165-177
pubmed: 35511377
Genes (Basel). 2019 Dec 05;10(12):
pubmed: 31817543
Biochim Biophys Acta. 2015 Mar;1852(3):406-20
pubmed: 25481835
Invest Ophthalmol Vis Sci. 2011 Oct 11;52(11):8042-6
pubmed: 21896857
J Hum Genet. 2010 Jun;55(6):327-35
pubmed: 20379205
Vision Res. 2012 Dec 15;75:60-70
pubmed: 23000274
Arch Ophthalmol. 2012 Jan;130(1):9-24
pubmed: 21911650
Ophthalmology. 2014 Feb;121(2):580-7
pubmed: 24199935
Ophthalmology. 2016 May;123(5):1151-60
pubmed: 26927203
Arch Ophthalmol. 1984 Jul;102(7):1004-10
pubmed: 6743076
Doc Ophthalmol. 2013 Feb;126(1):1-7
pubmed: 23073702
Eur J Hum Genet. 2016 Dec;24(12):1730-1738
pubmed: 27460420

Auteurs

Katja Čadonič (K)

Eye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.

Jana Sajovic (J)

Eye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.

Marko Hawlina (M)

Eye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.

Ana Fakin (A)

Eye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH